We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, DOJ Scrutiny Hurts St. Jude’s Earnings, Pipeline Development
FDA, DOJ Scrutiny Hurts St. Jude’s Earnings, Pipeline Development
July 29, 2011
A Justice Department investigation and changing endpoint requirements at the FDA are negatively impacting St. Jude Medical’s expectations for its cardiac rhythm management (CRM) and neuromodulation divisions.